320 related articles for article (PubMed ID: 16959614)
1. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.
Waerner T; Alacakaptan M; Tamir I; Oberauer R; Gal A; Brabletz T; Schreiber M; Jechlinger M; Beug H
Cancer Cell; 2006 Sep; 10(3):227-39. PubMed ID: 16959614
[TBL] [Abstract][Full Text] [Related]
2. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.
Lahsnig C; Mikula M; Petz M; Zulehner G; Schneller D; van Zijl F; Huber H; Csiszar A; Beug H; Mikulits W
Oncogene; 2009 Feb; 28(5):638-50. PubMed ID: 19015638
[TBL] [Abstract][Full Text] [Related]
3. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
4. Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis.
Kral M; Klimek C; Kutay B; Timelthaler G; Lendl T; Neuditschko B; Gerner C; Sibilia M; Csiszar A
FEBS J; 2017 Oct; 284(20):3484-3505. PubMed ID: 28837266
[TBL] [Abstract][Full Text] [Related]
5. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI.
Chaudhury A; Hussey GS; Ray PS; Jin G; Fox PL; Howe PH
Nat Cell Biol; 2010 Mar; 12(3):286-93. PubMed ID: 20154680
[TBL] [Abstract][Full Text] [Related]
7. ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549.
Song Q; Sheng W; Zhang X; Jiao S; Li F
Tumour Biol; 2014 Feb; 35(2):1377-82. PubMed ID: 24072492
[TBL] [Abstract][Full Text] [Related]
8. The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer.
Jansson AM; Csiszar A; Maier J; Nyström AC; Ax E; Johansson P; Schiavone LH
J Biol Chem; 2017 Sep; 292(37):15501-15511. PubMed ID: 28751379
[TBL] [Abstract][Full Text] [Related]
9. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression.
Csiszar A; Kutay B; Wirth S; Schmidt U; Macho-Maschler S; Schreiber M; Alacakaptan M; Vogel GF; Aumayr K; Huber LA; Beug H
Breast Cancer Res; 2014 Sep; 16(5):433. PubMed ID: 25212966
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells.
Lee EK; Jeon WK; Chae MY; Hong HY; Lee YS; Kim JH; Kwon JY; Kim BC; Park SH
Biochem Biophys Res Commun; 2010 Jan; 391(1):1021-7. PubMed ID: 19968960
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.
Oft M; Heider KH; Beug H
Curr Biol; 1998 Nov; 8(23):1243-52. PubMed ID: 9822576
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1).
Noguchi K; Dincman TA; Dalton AC; Howley BV; McCall BJ; Mohanty BK; Howe PH
J Biol Chem; 2018 Jul; 293(29):11401-11414. PubMed ID: 29871931
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
18. ILEI is an important intermediate participating in the formation of TGF-β1-induced renal tubular EMT.
Zhao X; Luo G; Fan Y; Ma X; Zhou J; Jiang H
Cell Biochem Funct; 2018 Mar; 36(2):46-55. PubMed ID: 29336056
[TBL] [Abstract][Full Text] [Related]
19. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
20. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
